Inflammatory bowel disease in the geriatric population

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article

Yahya Murad^1,*, Zaher A. Radi², Mohammed Murad³, Karen Hall⁴

Show Less

¹ University of Michigan- Geriatrics Center, 4260 Plymouth Road, Ann Arbor, MI 48109 USA

² Pfizer Worldwide Research and Development, 35 CambridgePark Dr., Cambridge, MA 02140 USA

³ University of Glasgow- Glasgow Dental Hospital, Restorative Department, 378 Sauchiehall Street, Glasgow G2 3JZ, UK

⁴ Geriatric Research, Education, and Training Center (GRECC), Ann Arbor VAHS, Ann Arbor, MI 48105 USA

*Author to whom correspondence should be addressed.

Academic Editor: Zaher Radi

Front. Biosci. (Elite Ed) 2011, 3(3), 945–954; https://doi.org/10.2741/E300

Published: 1 June 2011

(This article belongs to the Special Issue Inflammatory bowel disease -1)

Download PDF

Cite

Abstract

Inflammatory bowel disease (IBD) is a chronic disease that affects not only the young adults, but also the elderly. The elderly are more vulnerable and at higher risk from complications related to IBD. In this review we focus on IBD important features in the elderly and discuss the disease (1) epidemiology, (2) pathophysiology, (3) clinical manifestations and diagnosis, (4) prognosis, (6) therapy and (7) potential future research directions.

Keywords

Inflammatory bowel disease

Geriatric patients

Prognosis

Therapy

Review

Previous article in this issue

Next article in this issue

Front. Biosci. (Elite Ed) Print ISSN 1945-0494 Electronic ISSN 1945-0508